OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation

Journal of Experimental Medicine

Volumn 198, Issue 2, 2003, Pages 315-324

  Salek Ardakani, Shahram ^a   Song, Jianxun ^a   Halteman, Beth S ^a   Gebre Hiwot Jember, Amha ^a   Akiba, Hisaya ^b   Yagita, Hideo ^b   Croft, Michael ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergy; Asthma; Memory T cells; OX40; Th2

Indexed keywords

CD134 ANTIGEN; CD4 ANTIGEN;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRAIN; EOSINOPHILIA; FEMALE; HELPER CELL; HYPERACTIVITY; LUNG; LYMPH NODE; MEMORY CELL; MUCUS SECRETION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; SENSITIZATION; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; ANTIGENS, CD27; ANTIGENS, CD44; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HYPERSENSITIVITY; IMMUNOLOGIC MEMORY; INFLAMMATION; LUNG; MICE; MICE, INBRED C57BL; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; TH2 CELLS;

EID: 0042662863     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021937     Document Type: Article

References (40)

1. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-281.
2. Umetsu, D.T., J.J. McIntire, O. Akbari, C. Macaubas, and R.H. DeKruyff. 2002. Asthma: an apidemic of dysregulated immunity. Nat. Immunol. 3:715-720.
3. Croft, M., L.M. Bradley, and S.L. Swain. 1994. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152:2675-2685.
4. Byrne, J.A., J.L. Butler, and M.D. Cooper. 1988. Differential activation requirements for virgin and memory T cells. J. Immunol. 141:3249-3257.
5. Luqman, M., and K. Bottomly. Activation requirements for CD4+ T cells differing in CD45R expression. J. Immunol. 149:2300-2306.
6. Lu, P., X.D. Zhou, S.J. Chen, M. Moorman, A. Schoneveld, S. Morris, F.D. Finkelman, P. Linsley, E. Claasen, and W.C. Gause. 1995. Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune response. J. Immunol. 154:1078-1087.
7. Gause, W.C., P. Lu, X.D. Zhou, S.J. Chen, K.B. Madden, S.C. Morris, P.S. Linsley, F.D. Finkelman, and J.F. Urban. 1996. H. polygyrus: B7-independence of the secondary type 2 response. Exp. Parasitol. 84:264-273.
8. Harris, N.L., R.J. Peach, and F. Ronchese. 1999. CTLA4-Ig inhibits optimal T helper 2 cell development but not protective immunity or memory response to Nippostrongylus brasiliensis. Eur. J. Immunol. 29:311-316.
9. Gramaglia, I., A.D. Weinberg, M. Lemon, and M. Croft. 1998. OX40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 161:6510-6517.
10. Gramaglia, I., A. Jember, S.D. Pippig, A.D. Weinberg, N. Killeen, and M. Croft. 2000. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 165:3043-3050.
11. Rogers, P.R., J. Song, I. Gramaglia, N. Killeen, and M. Croft. 2001. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity. 15:445-455.
12. Mallett, S., S. Fossum, and A.N. Barclay. 1990. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes-a molecule related to nerve growth factor receptor. EMBO J. 9:1063-1068.
13. Calderhead, D.M., J.E. Buhlmann, A.J. van den Eertwegh, E. Claassen, R.J. Noelle, and H.P. Fell. 1993. Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151:5261-5271.
14. Baum, P.R., R.B. Gayle, F. Ramsdell, S. Srinivasan, R.A. Sorensen, M.L. Watson, M.F. Seldin, E. Baker, G.R. Sutherland, K.N. Clifford, et al. 1994. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13:3992-4001.
15. Al-Shamkhani, A., S. Mallett, M.H. Brown, W. James, and A.N. Barclay. 1997. Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells. J. Biol. Chem. 272:5275-5282.
16. Stuber, E., M. Neurath, D. Calderhead, H.P. Fell, and W. Strober. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity. 2:507-521.
17. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski, and G. Delespesse. 1997. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159:3838-3848.
18. Weinberg, A.D., K.W. Wegmann, C. Funatake, and R.H. Whitham. 1999. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 162:1818-1826.
19. Kopf, M., C. Ruedl, N. Schmitz, A. Gallimore, K. Lefrang, B. Ecabert, B. Odermatt, and M.F. Bachmann. 1999. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity. 11:699-708.
20. Chen, A.I., A.J. McAdam, J.E. Buhlmann, S. Scott, M.L. Lupher, E.A. Greenfield, P.R. Baum, W.C. Fanslow, D.M. Calderhead, G.J. Freeman, and A.H. Sharpe. 1999. Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity. 11:689-698.
21. Murata, K., N. Ishii, H. Takano, S. Miura, L.C. Ndhlovu, M. Nose, T. Noda, and K. Sugamura. 2000. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 191:365-374.
22. Jember, A.G., R. Zuberi, F.T. Liu, and M. Croft. 2001. Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J. Exp. Med. 193:387-392.
23. Akiba, H., Y. Miyahira, M. Atsuta, K. Takeda, C. Nohara, T. Futagawa, H. Matsuda, T. Aoki, H. Yagita, and K. Okumura. 2000. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J. Exp. Med. 191:375-380.
24. Tsukada, N., H. Akiba, T. Kobata, Y. Aizawa, H. Yagita, and K. Okumura. 2000. Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation. Blood. 95:2434-2439.
25. Higgins, L.M., S.A. McDonald, N. Whittle, N. Crockett, J.G. Shields, and T.T. MacDonald. 1999. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 162:486-493.
26. Yoshioka, T., A. Nakajima, H. Akiba, T. Ishiwata, G. Asano, S. Yoshino, H. Yagita, and K. Okumura. 2000. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur. J. Immunol. 30:2815-2823.
27. Nohara, C., H. Akiba, A. Nakajima, A. Inoue, C.S. Koh, H. Ohshima, H. Yagita, Y. Mizuno, and K. Okumura. 2001. Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells. J. Immunol. 166:2108-2115.
28. Bansal-Pakala, P., A.G. Jember, and M. Croft. 2001. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat. Med. 7:907-912.
29. Barnden, M.J., J. Allison, W.R. Heath, and F.R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34-40.
30. Akiba, H., H. Oshima, K. Takeda, M. Atsuta, H. Nakano, A. Nakajima, C. Nohara, H. Yagita, and K. Okumura. 1999. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J. Immunol. 162:7058-7066.
31. Kaminuma, O., H. Fujimura, K. Fushimi, A. Nakata, A. Sakai, S. Chishima, K. Ogawa, M. Kikuchi, H. Kikkawa, K. Akiyama, and A. Mori. 2001. Dynamics of antigen-specific helper T cells at the initiation of airway eosinophilic inflammation. Eur. J. Immunol. 31:2669-2679.
32. Hu, H., G. Huston, D. Duso, N. Lepak, E. Roman, and S.L. Swain. 2001. CD4(+) T cell effectors can become memory cells with high efficiency and without further division. Nat. Immunol. 2:705-710.
33. Harbertson, J., E. Biederman, K.E. Bennet, R.M. Kondrack, and L.M. Bradley. 2002. Withdrawal of stimulation may initiate the transition of effector to memory CD4 cells. J. Immunol. 168:1095-1102.
34. Cohn, L., R.J. Homer, A. Marinov, J. Rankin, and K. Bottomly. 1997. Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186:1737-1747.
35. Hansen, G., G. Berry, R.H. DeKruyff, and D.T. Umetsu. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:175-183.
36. Maxwell, J.R., A. Weinberg, R.A. Prell, and A.T. Vella. 2000. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J. Immunol. 164:107-112.
37. Harris, N.L., V. Watt, F. Ronchese, and G. Le Gros. 2002. Differential T cell function and fate in lymph node and nonlymphoid tissues. J. Exp. Med. 195:317-326.
38. Croft, M. Activation of naive, memory and effector T cells. 1994. Curr. Opin. Immunol. 6:431-437.
39. Gonzalo, J.A. J. Tian, T. Delaney, J. Corcoran, J.B. Rottman, J. Lora, A. Al-garawi, R. Kroczek, J.C. Gutierrez-Ramos, and A.J. Coyle. 2001. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat. Immunol. 2:597-604.
40. Coyle, A.J., S. Lehar, C. Lloyd, J. Tian, T. Delaney, S. Manning, T. Nguyen, T. Burwell, H. Schneider, J.A. Gonzalo, et al. 2000. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 13:95-105.